| Financial Year |
March 31 2022 |
| Monetary Funds |
912,896,921.02 |
| Held-for-trading Financial Assets |
46,097,293.34 |
| Notes Receivable |
-- |
| Accounts Receivable |
544,348,065.84 |
| Advances to Suppliers |
160,683,013.99 |
| Other Receivables |
51,154,913.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
128,565,731.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
134,346.14 |
| Total Current Assets |
1,852,109,466.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
937,717,275.39 |
| Investment Properties |
138,885,244.71 |
| Fixed Assetes |
425,674,516.52 |
| Under-construction Projects |
38,677,244.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
139,033,302.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
33,085,639.19 |
| Deferred Income Tax Assets |
225,141,958.47 |
| Other Non-Current Assets |
7,256,923.20 |
| Sub-Total of Non-Current Assets |
2,879,258,685.42 |
| Total Assets |
4,731,368,152.02 |
| Short-Term Loans |
366,398,113.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
132,293,899.98 |
| Accounts Payable |
306,684,640.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,397,426.31 |
| Taxes Payable |
37,130,382.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
91,934,317.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
146,051,300.52 |
| Other Current Liabilities |
4,038,249.86 |
| Sub-Total of Current Liabilities |
1,158,070,026.05 |
| Long-term Loans |
120,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
56,045,307.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
348,216,770.87 |
| Total Liabilities |
1,506,286,796.92 |
| Paid-In Capital(Or Share Stock) |
2,303,021,852.00 |
| Capital Surplus |
121,864,683.59 |
| Surplus Reserve |
261,923,364.85 |
| LESS:Treasury Stock |
24,115,500.00 |
| Undistributed Profits |
955,682,999.64 |
| Minority Stockholder's Interest |
69,026,308.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,156,055,046.67 |
| Owner's Equity（Stockholder's Equity） |
3,225,081,355.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,731,368,152.02 |
